Literature DB >> 24337841

Amplification of functional myeloid-derived suppressor cells during stem cell mobilization induced by granulocyte colony-stimulation-factor.

Xiao-Jian Zhu1, Jing Hu2, Li Sun1, Yin Xiao1, Zhi-Chao Chen1, Yong You1, Ping Zou1, Hong-Xiang Wang3, Zhao-Dong Zhong4.   

Abstract

The effects of granulocyte colony-stimulation-factor (G-CSF) on stem cell mobilization and its impact on the amplification of myeloid-derived suppressor cells (MDSCs) of donor mice were examined. A mouse model of stem cell mobilization was established by consecutive subcutaneous injection of 100 μg/kg G-CSF for 5 days. The blood from the donor mice was routinely examined during mobilization. Stem cells and MDSCs were analyzed by flow cytometry. The immunosuppressive molecules derived from MDSCs in serum and spleen, including hydrogen dioxide (H2O2) and nitric oxide (NO), and the activity of nitric oxide synthase (NOS) were determined during the mobilization. Apoptosis of T lymphocytes was assessed by using Annexin-V/PI. During stem cell mobilization, the number of lymphocytes and white blood cells in the peripheral blood was increased, and peaked on the 4th day. The number of stem cells in G-CSF-treated mice was significantly greater than that in controls (P<0.01). The expansions of MSDCs were also observed after G-CSF mobilization, with a more notable rate of growth in the peripheral blood than in the spleen. The activity of NOS and the production of NO were increased in the donor mice, and the serum H2O2 levels were approximately 4-fold greater than the controls. Consequently, apoptosis of T lymphocytes was increased and showed a positive correlation with the elevated percentage of MDSCs. It was concluded that G-CSF could provide sufficient peripheral blood stem cells for transplantation. Exogenous administration of G-CSF caused the accumulation of MDSCs in the peripheral blood and the spleen, which could lead to apoptosis of T lymphocytes and may offer a new strategy for the prevention and treatment of graft versus host disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24337841     DOI: 10.1007/s11596-013-1204-x

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  15 in total

1.  Granulocyte colony-stimulating factor reduces the capacity of blood mononuclear cells to induce graft-versus-host disease: impact on blood progenitor cell transplantation.

Authors:  D Zeng; S Dejbakhsh-Jones; S Strober
Journal:  Blood       Date:  1997-07-01       Impact factor: 22.113

2.  Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion.

Authors:  Anne-Sophie Dugast; Thomas Haudebourg; Flora Coulon; Michèle Heslan; Fabienne Haspot; Nicolas Poirier; Romain Vuillefroy de Silly; Claire Usal; Helga Smit; Bernard Martinet; Pamela Thebault; Karine Renaudin; Bernard Vanhove
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

Review 3.  Discovery and validation of graft-versus-host disease biomarkers.

Authors:  Sophie Paczesny
Journal:  Blood       Date:  2012-11-19       Impact factor: 22.113

Review 4.  Role of immature myeloid cells in mechanisms of immune evasion in cancer.

Authors:  Sergei Kusmartsev; Dmitry I Gabrilovich
Journal:  Cancer Immunol Immunother       Date:  2005-07-27       Impact factor: 6.968

5.  Superantigen-induced CD4 T cell tolerance mediated by myeloid cells and IFN-gamma.

Authors:  L S Cauley; E E Miller; M Yen; S L Swain
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

6.  Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13.

Authors:  Steven L Highfill; Paulo C Rodriguez; Qing Zhou; Christine A Goetz; Brent H Koehn; Rachelle Veenstra; Patricia A Taylor; Angela Panoskaltsis-Mortari; Jonathan S Serody; David H Munn; Jakub Tolar; Augusto C Ochoa; Bruce R Blazar
Journal:  Blood       Date:  2010-08-31       Impact factor: 22.113

7.  Granulocyte-colony stimulating factor drives the in vitro differentiation of human dendritic cells that induce anergy in naïve T cells.

Authors:  Maura Rossetti; Silvia Gregori; Maria Grazia Roncarolo
Journal:  Eur J Immunol       Date:  2010-10-19       Impact factor: 5.532

8.  Immunosuppression during acute Trypanosoma cruzi infection: involvement of Ly6G (Gr1(+))CD11b(+ )immature myeloid suppressor cells.

Authors:  Oscar Goñi; Pilar Alcaide; Manuel Fresno
Journal:  Int Immunol       Date:  2002-10       Impact factor: 4.823

Review 9.  Mobilizing stem cells from normal donors: is it possible to improve upon G-CSF?

Authors:  A F Cashen; H M Lazarus; S M Devine
Journal:  Bone Marrow Transplant       Date:  2007-03-19       Impact factor: 5.483

10.  New strategies for stem cell mobilization.

Authors:  Roberto M Lemoli
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-10-03       Impact factor: 2.576

View more
  2 in total

1.  Phenotypically resembling myeloid derived suppressor cells are increased in children with HIV and exposed/infected with Mycobacterium tuberculosis.

Authors:  Nelita Du Plessis; Ruschca Jacobs; Andrea Gutschmidt; Zhuo Fang; Paul D van Helden; Manfred B Lutz; Anneke C Hesseling; Gerhard Walzl
Journal:  Eur J Immunol       Date:  2016-12-16       Impact factor: 5.532

2.  Splenectomy suppresses growth and metastasis of hepatocellular carcinoma through decreasing myeloid-derived suppressor cells in vivo.

Authors:  Xin Long; Jian Wang; Jian-Ping Zhao; Hui-Fang Liang; Peng Zhu; Qi Cheng; Qian Chen; Yan-Hui Wu; Zhan-Guo Zhang; Bi-Xiang Zhang; Xiao-Ping Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-10-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.